A detailed history of Assenagon Asset Management S.A. transactions in Chimerix Inc stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 320,916 shares of CMRX stock, worth $311,288. This represents 0.0% of its overall portfolio holdings.

Number of Shares
320,916
Previous 404,709 20.7%
Holding current value
$311,288
Previous $356,000 16.29%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$0.77 - $1.07 $64,520 - $89,658
-83,793 Reduced 20.7%
320,916 $298,000
Q2 2024

Jul 18, 2024

SELL
$0.87 - $1.05 $43,290 - $52,246
-49,759 Reduced 10.95%
404,709 $356,000
Q1 2024

Apr 24, 2024

SELL
$0.91 - $1.26 $40,879 - $56,602
-44,923 Reduced 9.0%
454,468 $481,000
Q4 2023

Jan 17, 2024

BUY
$0.9 - $1.06 $65,447 - $77,082
72,719 Added 17.04%
499,391 $479,000
Q3 2023

Nov 06, 2023

BUY
$0.94 - $1.23 $251,021 - $328,464
267,044 Added 167.29%
426,672 $409,000
Q2 2023

Jul 25, 2023

SELL
$1.1 - $1.54 $125,528 - $175,740
-114,117 Reduced 41.69%
159,628 $193,000
Q1 2023

Apr 18, 2023

BUY
$1.19 - $2.09 $11,526 - $20,243
9,686 Added 3.67%
273,745 $344,000
Q4 2022

Jan 12, 2023

SELL
$1.67 - $2.35 $39,017 - $54,905
-23,364 Reduced 8.13%
264,059 $491,000
Q3 2022

Oct 27, 2022

BUY
$1.81 - $2.76 $130,584 - $199,122
72,146 Added 33.51%
287,423 $555,000
Q2 2022

Jul 27, 2022

BUY
$1.34 - $5.34 $288,471 - $1.15 Million
215,277 New
215,277 $448,000
Q2 2019

Aug 12, 2019

SELL
$2.05 - $4.32 $445,487 - $938,783
-217,311 Closed
0 $0
Q4 2018

Jan 23, 2019

SELL
$2.24 - $3.9 $68,503 - $119,269
-30,582 Reduced 12.34%
217,311 $558,000
Q3 2018

Oct 29, 2018

SELL
$3.58 - $4.9 $1.66 Million - $2.27 Million
-463,605 Reduced 65.16%
247,893 $964,000
Q2 2018

Jul 17, 2018

BUY
$4.43 - $5.14 $1.91 Million - $2.21 Million
430,891 Added 153.56%
711,498 $3.39 Million
Q1 2018

Apr 30, 2018

BUY
$4.65 - $5.9 $1.3 Million - $1.66 Million
280,607 New
280,607 $1.46 Million

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $85M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.